Equities researchers at StockNews.com initiated coverage on shares of Cyclacel Pharmaceuticals (NASDAQ:CYCC – Get Free Report) in a note issued to investors on Friday. The brokerage set a “sell” ...

Verzenio plus Faslodex improved progression-free survival in HR+/HER2– advanced breast cancer after CDK/6i failure, with a ...

Amgen and AstraZeneca have reported complete outcomes from the registrational Phase III WAYPOINT trial of Tezspire ...

Cyclin dependent kinase (CDK) 4/6 inhibitors are targeted agents which act on cyclin-D and these combined with hormonal therapy have been approved for the treatment of locally advanced or metastatic ...

Their new study identifies ... A New Way to Predict Cancer's Spread? Scientists Look at 'Stickiness' of Tumor Cells Mar. 5, 2025 — By assessing how 'sticky' tumor cells are, researchers have ...

When the Cancer moon connects with spontaneous Uranus on Sunday, you might make a new friend. There’s always room for one more! Or a group that you’ve wanted to join for a while might welcome ...

After hours: March 6 at 4:05:05 PM EST Loading Chart for PRLD ...

Curling back into your shell? Last week’s new moon had you aiming for the stars! What happened? Okay, maybe you made too many moves, too fast. Use today’s first quarter moon to regroup.